Lytic granules, secretory lysosomes and disease

Current Opinion in Immunology

Volumn 15, Issue 5, 2003, Pages 516-521

  Clark, Richard ^a   Griffiths, Gillian M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 PHOSPHONOPROPIONIC ACID; ADAPTOR PROTEIN; ANTIBODY; CATHEPSIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; GRANZYME A; GRANZYME B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; MONOPHENOL MONOOXYGENASE; MYOSIN V; NOCODAZOLE; PERFORIN; PROTEIN; PROTEIN SUBUNIT; PROTEOCHONDROITIN SULFATE; RAB PROTEIN; SOMATOMEDIN B RECEPTOR; T LYMPHOCYTE RECEPTOR;

ACIDITY; ALBINISM; ANTIGEN PRESENTING CELL; APOPTOSIS; BIOGENESIS; CELL DEATH; CELL KINETICS; CELL MATURATION; CELL ORGANELLE; CHEDIAK HIGASHI SYNDROME; CYTOTOXIC T LYMPHOCYTE; DENSE BODY; GRANULE CELL; GRISCELLI SYNDROME; HEMATOPOIETIC CELL; HUMAN; IMMUNE DEFICIENCY; LYSOSOME; MELANOCYTE; MELANOSOME; NATURAL KILLER CELL; NONHUMAN; OCULAR ALBINISM; PH; POLYMERIZATION; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; SECRETION; SYNAPSE; THROMBOCYTE;

EID: 0141741403     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00113-4     Document Type: Review

References (50)

1. Griffiths G.M. Albinism and immunity: what's the link? Curr Mol Med. 2:2002;479-483.
2. Burkhardt J.K., Hester S., Lapham C.K., Argon Y. The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments. J Cell Biol. 111:1990;2327-2340.
3. Peters P.J., Borst J., Oorschot V., Fukuda M., Krahenbuhl O., Tschopp J., Slot J.W., Geuze H.J. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med. 173:1991;1099-1109.
4. Masson D., Peters P.J., Geuze H.J., Borst J., Tschopp J. Interaction of chondroitin sulfate with perforin and granzymes of cytolytic T-cells is dependent on pH. Biochemistry. 29:1990;11229-11235.
5. Stinchcombe J.C., Page L.J., Griffiths G.M. Secretory lysosome biogenesis in cytotoxic T lymphocytes from normal and Chediak Higashi syndrome patients. Traffic. 1:2000;435-444.
6. Huttner W.B., Tooze S.A. Biosynthetic protein transport in the secretory pathway. Curr Opin Cell Biol. 1:1989;648-654.
7. Metkar S.S., Wang B., Aguilar-Santelises M., Raja S.M., Uhlin-Hansen L., Podack E., Trapani J.A., Froelich C.J. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity. 16:2002;417-428.
8. Raja S.M., Wang B., Dantuluri M., Desai U.R., Demeler B., Spiegel K., Metkar S.S., Froelich C.J. Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J Biol Chem. 277:2002;49523-49530.
9. Griffiths G.M., Isaaz S. Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor. J Cell Biol. 120:1993;885-896.
10. Motyka B., Korbutt G., Pinkoski M.J., Heibein J.A., Caputo A., Hobman M., Barry M., Shostak I., Sawchuk T., Holmes C.F.et al. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell. 103:2000;491-500.
11. Trapani J.A., Sutton V.R., Thia K.Y., Li Y.Q., Froelich C.J., Jans D.A., Sandrin M.S., Browne K.A. A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death. J Cell Biol. 160:2003;223-233 In this paper, the authors show that target-cell killing proceeds when endocytosis is blocked.
12. Chuang E., Alegre M.L., Duckett C.S., Noel P.J., Vander Heiden M.G., Thompson C.B. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J Immunol. 159:1997;144-151.
13. Bossi G., Griffiths G.M. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med. 5:1999;90-96.
14. Blott E.J., Bossi G., Clark R., Zvelebil M., Griffiths G.M. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J Cell Sci. 114:2001;2405-2416.
15. Bossi G., Stinchcombe J.C., Page L.J., Griffiths G.M. Sorting out the multiple roles of Fas ligand. Eur J Cell Biol. 79:2000;539-543.
16. Blott E.J., Griffiths G.M. Secretory lysosomes. Nat Rev Mol Cell Biol. 3:2002;122-131.
17. Grassme H., Kirschnek S., Riethmueller J., Riehle A., von Kurthy G., Lang F., Weller M., Gulbins E. CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science. 290:2000;527-530.
18. Takayama H., Trenn G., Kruisbeek A., Kanagawa O., Sitkovsky M.V. T cell antigen receptor triggered exocytosis in cytotoxic T lymphocytes is inhibited by soluble, but not immobilized monoclonal antibodies to Lyt-2 antigen. J Immunol. 139:1987;1014-1021.
19. Takayama H., Trenn G., Humphrey W. Jr., Bluestone J.A., Henkart P.A., Sitkovsky M.V. Antigen receptor-triggered secretion of a trypsin-type esterase from cytotoxic T lymphocytes. J Immunol. 138:1987;566-569.
20. Kupfer A., Dennert G., Singer S.J. Polarization of the Golgi apparatus and the microtubule-organizing center within cloned natural killer cells bound to their targets. Proc Natl Acad Sci USA. 80:1983;7224-7228.
21. Stinchcombe J.C., Bossi G., Booth S., Griffiths G.M. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity. 15:2001;751-761.
22. Trambas C.M., Griffiths G.M. Delivering the kiss of death. Nat Immunol. 4:2003;399-403.
23. Barak Y., Nir E. Chediak-Higashi syndrome. Am J Pediatr Hematol Oncol. 9:1987;42-55.
24. Ward D.M., Griffiths G.M., Stinchcombe J.C., Kaplan J. Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic. 1:2000;816-822.
25. Ward D.M., Shiflett S.L., Huynh D., Vaughn M.B., Prestwich G., Kaplan J. Use of expression constructs to dissect the functional domains of the CHS/beige protein: identification of multiple phenotypes. Traffic. 4:2003;403-415.
26. Tchernev V.T., Mansfield T.A., Giot L., Kumar A.M., Nandabalan K., Li Y., Mishra V.S., Detter J.C., Rothberg J.M., Wallace M.R.et al. The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med. 8:2002;56-64 This paper describes one of the first clues as to how the CHS/Lyst protein might act.
27. Griscelli C., Durandy A., Guy-Grand D., Daguillard F., Herzog C., Prunieras M. A syndrome associating partial albinism and immunodeficiency. Am J Med. 65:1978;691-702.
28. Menasche G., Pastural E., Feldmann J., Certain S., Ersoy F., Dupuis S., Wulffraat N., Bianchi D., Fischer A., Le Deist F., de Saint Basile G. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet. 25:2000;173-176.
29. Sanal O., Ersoy F., Tezcan I., Metin A., Yel L., Menasche G., Gurgey A., Berkel I., de Saint Basile G. Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity. J Clin Immunol. 22:2002;237-243 A fascinating study of genotype-phenotype correlation.
30. Bahadoran P., Busca R., Chiaverini C., Westbroek W., Lambert J., Bille K., Valony G., Fukuda M., Naeyaert J.M., Ortonne J.P., Ballotti R. Characterization of the molecular defects in Rab27a, caused by RAB27A missense mutations found in patients with Griscelli syndrome. J Biol Chem. 278:2003;11386-11392.
31. Haddad E.K., Wu X., Hammer J.A. III, Henkart P.A. Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice. J Cell Biol. 152:2001;835-842.
32. Stinchcombe J.C., Barral D.C., Mules E.H., Booth S., Hume A.N., Machesky L.M., Seabra M.C., Griffiths G.M. Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J Cell Biol. 152:2001;825-834.
33. Hume A.N., Collinson L.M., Hopkins C.R., Strom M., Barral D.C., Bossi G., Griffiths G.M., Seabra M.C. The leaden gene product is required with Rab27a to recruit myosin Va to melanosomes in melanocytes. Traffic. 3:2002;193-202.
34. Hermansky F., Cieslar P., Matousova O., Smetana K. Proceedings: Study of albinism in relation to Hermansky-Pudlak syndrome. Thromb Diath Haemorrh. 34:1975;360.
35. Anderson P.D., Huizing M., Claassen D.A., White J., Gahl W.A. Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics. Hum Genet. 113:2003;10-17.
36. Chiang P.W., Oiso N., Gautam R., Suzuki T., Swank R.T., Spritz R.A. The Hermansky-Pudlak Syndrome 1 (HPS1) and HPS4 Proteins Are Components of Two Complexes, BLOC-3 and BLOC-4, Involved in the Biogenesis of Lysosome-related Organelles. J Biol Chem. 278:2003;20332-20337.
37. Ciciotte S.L., Gwynn B., Moriyama K., Huizing M., Gahl W.A., Bonifacino J.S., Peters L.L. Cappuccino, a mouse model of Hermansky-Pudlak syndrome, encodes a novel protein that is part of the pallidin-muted complex (BLOC-1). Blood. 101:2003;4402-4407.
38. Martina JA, Moriyama K, Bonifacino JS: BLOC-3, a protein complex containing the Hermansky-Pudlak syndrome gene products HPS1 and HPS4. J Biol Chem 2003 (published online 19 July 2003) DOI: 10.1074/jbc.M301294200.
39. Zhang Q., Zhao B., Li W., Oiso N., Novak E.K., Rusiniak M.E., Gautam R., Chintala S., O'Brien E.P., Zhang Y.et al. Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6. Nat Genet. 33:2003;145-153.
40. Swank R.T., Novak E.K., McGarry M.P., Rusiniak M.E., Feng L. Mouse models of Hermansky Pudlak syndrome: a review. Pigment Cell Res. 11:1998;60-80.
41. Chiang P.W., Oiso N., Gautam R., Suzuki T., Swank R.T., Spritz R.A. The Hermansky-Pudlak syndrome 1 (HPS1) and HPS4 proteins are components of the two complexes BLOC-3 and BLOC-4, involved in the biogenesis of the lysosome related organelles. J Biol Chem. 278:2003;20322-20327.
42. Kantheti P., Qiao X., Diaz M.E., Peden A.A., Meyer G.E., Carskadon S.L., Kapfhamer D., Sufalko D., Robinson M.S., Noebels J.L., Burmeister M. Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron. 21:1998;111-122.
43. Feng L., Seymour A.B., Jiang S., To A., Peden A.A., Novak E.K., Zhen L., Rusiniak M.E., Eicher E.M., Robinson M.S.et al. The beta3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Hum Mol Genet. 8:1999;323-330.
44. Zhen L., Jiang S., Feng L., Bright N.A., Peden A.A., Seymour A.B., Novak E.K., Elliott R., Gorin M.B., Robinson M.S., Swank R.T. Abnormal expression and subcellular distribution of subunit proteins of the AP-3 adaptor complex lead to platelet storage pool deficiency in the pearl mouse. Blood. 94:1999;146-155.
45. Huizing M., Scher C.D., Strovel E., Fitzpatrick D.L., Hartnell L.M., Anikster Y., Gahl W.A. Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. Pediatr Res. 51:2002;150-158.
46. Sugita M., Cao X., Watts G.F., Rogers R.A., Bonifacino J.S., Brenner M.B. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity. 16:2002;697-706.
47. Nakagawa T., Setou M., Seog D., Ogasawara K., Dohmae N., Takio K., Hirokawa N. A novel motor, KIF13A, transports mannose-6-phosphate receptor to plasma membrane through direct interaction with AP-1 complex. Cell. 103:2000;569-581.
48. Dell'Angelica E.C., Mullins C., Caplan S., Bonifacino J.S. Lysosome-related organelles. FASEB J. 14:2000;1265-1278.
49. Huizing M., Anikster Y., Gahl W.A. Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic. 1:2000;823-835.
50. Starcevic M., Nazarian R., Dell'Angelica E.C. The molecular machinery for the biogenesis of lysosome-related organelles: lessons from Hermansky-Pudlak syndrome. Semin Cell Dev Biol. 13:2002;271-278.